BioSpace News Archive

BiondVax Pharmaceuticals Ltd., developer of the M-001 universal influenza vaccine candidate, reported it will present this week at the 18th MIXiii-BIOMED Conference and Exhibition in Tel Aviv, Israel.

ANSYS multiphysics solutions are enabled on Samsung’s latest FinFET technology

NanoViricides, Inc. a company with novel platform technology to meet unmet medical needs in treating difficult and life-threatening viral diseases, reports that it has successfully completed manufacture of the drug for the upcoming GLP Safety/Toxicology study of its lead candidate in several kilogram quantities.

ElevateBio announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and entrepreneurs.

Understory, the weather network and analytics company, announced that is has closed a $5.25 million Series B funding round led by True Ventures with participation from 4490 Ventures and Revolution’s Rise of the Rest Seed Fund.

CannTrust Holdings Inc., announced it has finalized a Letter of Intent with Société québécoise du cannabis to provide Quebec with high quality cannabis for the recreational market.

AGC Biologics, announced the appointment of Christopher Holt as Site Head/General Manager of its Bothell, Washington operations.

DLH Holdings Corp. announced that management will participate in the following events for institutional investors during May, 2019

Smith & Nephew, the global medical technology business, announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology.

Additional funding further extends runway for Trovagene to accelerate clinical development of onvansertib for the treatment of cancers where new therapeutic options are most needed